Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Genpharmasec Annual General Meeting

Genpharmasec Limited conducted its 34th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including the adoption of FY26 financial statements and director re-appointments.

Source

BSE filing, NSE: ADIRASA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Genpharmasec Ltd: key numbers

Share price
₹0.97
Market cap
₹53.71 Cr
Revenue (annual)
₹139.9 Cr
Net profit (annual)
₹1.60 Cr
P/E (TTM)
-440.9×Sector 46.1×
Promoter holding
32.06%+2.08% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Genpharmasec Ltd

All →

Other annual general meeting announcements

All →